PHILADELPHIA--(BUSINESS WIRE)--The 2019 BIO International Convention, the premier life sciences event running through June 6 at the Philadelphia Convention Center, will open its third day of programming with a keynote from Jamie Dimon, Chairman and CEO of JPMorgan Chase. Dimon will be interviewed by BIO President and CEO Jim Greenwood on how emerging biotech companies can best position themselves in the global economy. Dimon will also share insight on how the industry can improve employee satisfaction and cultivate a diverse and inclusive biotech community.
The day’s programming will also include compelling sessions with industry thought leaders, rising start-up companies as well as a fireside chat with Merck Chairman and CEO Ken Frazier. During his fireside chat, Frazier will discuss how Merck approaches investment in research and how that translates to delivering innovative, lifesaving medicines and vaccines and sustainable value for its stakeholders.
Wednesday, June 5, Highlights Include:
Dimon, Chairman and CEO of JPMorgan Chase
9:00 – 10:45 am | Ballroom AB
- PLEASE NOTE: Keynotes are open to Convention Access and Partnering Attendees. Filming is not permitted. Seating is first-come, first-served.
Fireside Chat: Kenneth
C. Frazier, Chairman of the Board and Chief Executive Officer, Merck &
11:00 – 11:45 am | 103ABC, Level 100
During his fireside chat, Kenneth Frazier will discuss how Merck is delivering innovative, lifesaving medicines and vaccines as well as long-term and sustainable value to its stakeholders.
Super Session: Dealmakers'
Intentions: 2019 Market Outlook
12:15 – 1:30 pm | 113ABC, Level 100
A panel of deal-makers will explore the impact market forces will have on pharmaceutical and biotech companies as they strive to make the next big deal.
Super Session: The
Art & Science of R&D Innovation and Productivity
12:15 – 1:30 pm | 103ABC, Level 100
A panel will seek to understand how companies of various sizes think about R&D innovation and productivity today, from operating and business models to measurement.
Super Session: The
State of the Vaccine Industry - Stimulating Sustainable Growth
3:00 – 4:15 pm | 113ABC, Level 100
This session will focus on the various ways vaccine companies and partners can stimulate continued growth of the vaccine business by fostering innovation with new target vaccines, new technology and solutions to access issues that will increase immunization rates.
10:30 am - 1:00 pm | Exhibitor Hall, 3971, Level 200
Designed to provide start-up-level companies with the opportunity to engage key members of the investment community and venture philanthropy groups. BIO attendees can watch these impressive companies pitch their products to a panel of investor judges.
BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIOtechNOW is BIO's blog chronicling “innovations transforming our world” and the BIO Newsletter is the organization’s bi-weekly email newsletter. Subscribe to the BIO Newsletter.